Baxter International Inc. (BAX)
NYSE: BAX
· Real-Time Price · USD
21.96
0.25 (1.15%)
At close: Sep 26, 2025, 3:59 PM
22.03
0.32%
After-hours: Sep 26, 2025, 07:51 PM EDT
Baxter International Revenue Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Healthcare Systems and Technologies Revenue | 767M | 704M | 784M | 752M | 748M | 667M | 2.27B | 744M | 550M | 523M | 552M | 525M | 528M | 521M | 604M | 589M | 546M | 552M | 546M | 540M | 485M | 527M |
Healthcare Systems and Technologies Revenue Growth | +8.95% | -10.20% | +4.26% | +0.53% | +12.14% | -70.60% | +204.97% | +35.27% | +5.16% | -5.25% | +5.14% | -0.57% | +1.34% | -13.74% | +2.55% | +7.88% | -1.09% | +1.10% | +1.11% | +11.34% | -7.97% | n/a |
Medical Products And Therapies Revenue | 1.32B | 1.26B | 1.31B | 1.34B | 1.32B | 1.23B | 3.75B | 1.26B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Medical Products And Therapies Revenue Growth | +4.60% | -3.96% | -2.09% | +1.51% | +7.57% | -67.25% | +198.33% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmaceuticals Revenue | 612M | 581M | 643M | 588M | 602M | 578M | 596M | 580M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmaceuticals Revenue Growth | +5.34% | -9.64% | +9.35% | -2.33% | +4.15% | -3.02% | +2.76% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emea Revenue | 344M | 297M | n/a | 347M | 844M | 778M | 991M | 852M | 762M | 714M | 1.58B | 692M | 738M | 699M | 1.48B | 779M | 783M | 738M | 1.29B | 777M | 731M | 754M | 1.29B | 1.22B | 1.19B | 1.12B | 772M | 707M | 758M | 724M |
Emea Revenue Growth | +15.82% | n/a | -100.00% | -58.89% | +8.48% | -21.49% | +16.31% | +11.81% | +6.72% | -54.95% | +129.05% | -6.23% | +5.58% | -52.87% | +90.37% | -0.51% | +6.10% | -42.79% | +66.02% | +6.29% | -3.05% | -41.51% | +5.31% | +2.60% | +6.52% | +45.08% | +9.19% | -6.73% | +4.70% | n/a |
United States Revenue | 1.54B | 1.49B | 894M | 1.5B | 1.8B | 1.66B | 5.23B | 1.77B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
United States Revenue Growth | +3.09% | +66.67% | -40.40% | -16.53% | +8.32% | -68.30% | +196.38% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Western Europe, Canada, Japan, Australia And New Zealand Revenue | 930M | 838M | 258M | 852M | 1.17B | 1.16B | 3.4B | 1.09B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Western Europe, Canada, Japan, Australia And New Zealand Revenue Growth | +10.98% | +224.81% | -69.72% | -27.24% | +1.39% | -66.07% | +212.29% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 689M | 703M | 761M | 754M | 723M | 729M | 977M | 744M | 964M | 995M | 912M | 941M | 970M | 1.05B | 885M | 680M | 675M | 627M | 650M | 601M | 590M | 628M | 666M | 627M | 641M | 601M | 629M | 684M | 681M | 622M | 697M | 680M | 630M | 564M | 663M | 726M | 709M | 641M | 733M | 794M | 783M | 784M |
Selling, General, and Administrative Revenue Growth | -1.99% | -7.62% | +0.93% | +4.29% | -0.82% | -25.38% | +31.32% | -22.82% | -3.12% | +9.10% | -3.08% | -2.99% | -7.79% | +18.87% | +30.15% | +0.74% | +7.66% | -3.54% | +8.15% | +1.86% | -6.05% | -5.71% | +6.22% | -2.18% | +6.66% | -4.45% | -8.04% | +0.44% | +9.49% | -10.76% | +2.50% | +7.94% | +11.70% | -14.93% | -8.68% | +2.40% | +10.61% | -12.55% | -7.68% | +1.40% | -0.13% | n/a |
Research and Development Revenue | 134M | 140M | 211M | 129M | 130M | 120M | 172M | 133M | 165M | 164M | 155M | 151M | 148M | 150M | 138M | 129M | 139M | 128M | 135M | 123M | 117M | 146M | 156M | 144M | 166M | 129M | 175M | 166M | 174M | 140M | 182M | 150M | 155M | 127M | 157M | 159M | 195M | 136M | 161M | 148M | 151M | 143M |
Research and Development Revenue Growth | -4.29% | -33.65% | +63.57% | -0.77% | +8.33% | -30.23% | +29.32% | -19.39% | +0.61% | +5.81% | +2.65% | +2.03% | -1.33% | +8.70% | +6.98% | -7.19% | +8.59% | -5.19% | +9.76% | +5.13% | -19.86% | -6.41% | +8.33% | -13.25% | +28.68% | -26.29% | +5.42% | -4.60% | +24.29% | -23.08% | +21.33% | -3.23% | +22.05% | -19.11% | -1.26% | -18.46% | +43.38% | -15.53% | +8.78% | -1.99% | +5.59% | n/a |